VBIV - צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים VBI Vaccines Inc.

VBI Vaccines Inc. minimizes costs by outsourcing production and testing to third-party contractors. The GURU.Markets terminal displays the sales growth trend compared to the same period last year over a 12-month period, where the value of 834.50 corresponds to the current metric. This occurs amid the competition for the immuno-oncology market and the utilization of a unique VLP platform to generate a potent immune response against hepatitis B.
VBI Vaccines, Inc. (VBIV) - פילוחי מדדים ודוחות פיננסיים

This indicator captures revenue dynamics over a rolling twelve-month period, allowing for the determination of the business maturity stage and the identification of signs of stagnating operating income. This chart of trailing twelve-month revenue changes for VBI Vaccines Inc. (VBIV) demonstrates a loss of competitive advantages due to the liquidation of key assets, rendering the asset extremely risky compared to pharmaceutical behemoths.